By Lee E. Kirsch, Ph.D., Associate Professor, Division of Pharmaceutics, University of Iowa * Permission to print the following article is granted by the National Institute of Pharmaceutical Technology and Education (NIPTE). The future of the pharmaceutical technology workforce is of profound concern to those of us involved directly in or in support of the pharmaceutical industry. Historically, pharmaceutical innovations and discoveries have propelled this industry to great successes manifested in decades of strong economic growth and advances in effective drug therapy. The vitality of this technology-intensive industry has been attributed in large part to the highly-trained engineers and scientists who serve as a constant source of innovative ideas. The possibility that this vitality may be stagnating due to a lack of interest in science by the current crop of students, or a lack of a strategic focus in the development of human resources, has troubled both policy-makers and leading scientists. Our future ability to capitalize on new biomedical discoveries and generate new business and growth is at risk, in part, because of a lack of support for the physical sciences and engineering. These disciplines directly impact progress in the technologies used to develop and commercialize biomedical discoveries. The National Institute of Pharmaceutical Technology and Education (NIPTE) seeks to remedy this situation through two strategic objectives aimed at: 1) implementation of a technology research roadmap to advance the basic sciences supporting the development and manufacture of pharmaceuticals; and 2) implementation of an advanced curriculum to nurture the highly-trained professionals needed to advance our capabilities in pharmaceutical technology disciplines. The former strategic objective is elaborated in a Pharmaceutical Technology Roadmap, a document currently being finalized by NIPTE participants. The NIPTE approach to achieving the latter, a new curriculum, is described herein. Is there really an impending crisis in maintaining and advancing pharmaceutical
Products & Services
Biotechnology and Pharmaceutical Manufacturing Services
Biotechnology and pharmaceutical manufacturing services active pharmaceutical ingredients, sterilize biomedical components or materials, validate processes or packaging, and formulate drug or medicinal preparations on a contract basis.
Stability Chambers and Rooms
Stability chambers and stability rooms are temperature-controlled and humidity-controlled environmental units that provide stable conditions for storage and testing purposes.
Colleges and Universities
Colleges and universities provide for-credit courses, degrees or certificate programs in engineering, science, technology, management or other specialized subject areas.
Nanomaterials have features or particle sizes in the range of 1 to 100 nm.
Topics of Interest
By Lee E. Kirsch, Ph.D., Associate Professor, Division of Pharmaceutics, University of Iowa In an effort to address these issues, the NIPTE consortium ( ; see Box) has set out to leverage its...
The University of Puerto Rico is very strong in engineering and life sciences training, and is an active member of the National Institute for Pharmaceutical Technology and Education (NIPTE) which is...
This quick, one-time registration gives you access to members-only site benefits. Agnes Shanley, Editor in Chief The petroleum industrys current problems, and accusations of post-hurricane price...
Operational Excellence & Lean Six Sigma Wyeths Charlie Portwood: Focus on QbD Before ICH Q8-10 Moheb Nasr on Heparins Lessons Darrell Abernathy: USP Tests to be Updated Dr. Jawed...
By Thomas Friedli, University of St. Gallen and Prabir Basu, Director, NIPTE Few managers of pharmaceutical companies see manufacturing as a competitive advantage today. Increasing cost pressures in...